Security key
29384C108
Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA)
CUSIP: 29384C108
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 24,778,477
- Total 13F value
- $301,833,417
- Share change
- -1,094,382
- SEC-reported price per share
- $12.18
- Number of holders
- 35
- Value change
- -$12,927,920
- Number of buys
- 12
- Number of sells
- 31
- Shares outstanding
- 38,346,880
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
35
Top holders
10
TRDA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Entrada Therapeutics, Inc. SEC filings
Entrada Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29384C108
Recent filing periods:
Ownership snapshot
Top reported holders of TRDA - Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F
3/4/5
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
BAKER BROS. ADVISORS LP leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAKER BROS. ADVISORS LP's linked filing trail.
Comparable ownership
Top 5
BAKER BROS. ADVISORS LP
12%
MPM ASSET MANAGEMENT LLC
12%
5AM Venture Management, LLC
11%
WELLINGTON MANAGEMENT GROUP LLP
6.6%
PRICE T ROWE ASSOCIATES INC /MD/
6.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
Company
|
12%
|
$44,174,000
4,704,419 shares
|
— | 31 Mar 2022 |
| MPM ASSET MANAGEMENT LLC |
13F
Company
|
12%
|
$41,558,000
4,425,784 shares
|
— | 31 Mar 2022 |
| 5AM Venture Management, LLC |
13F
Company
|
11%
|
$41,395,000
4,408,379 shares
|
— | 31 Mar 2022 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
6.6%
|
$23,816,000
2,543,102 shares
|
— | 31 Mar 2022 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
6.5%
|
$23,425,000
2,494,714 shares
|
— | 31 Mar 2022 |
| Redmile Group, LLC |
3/4/5
13F
10%+ Owner · Company
|
5.1%
from 13F
|
$31,251,176
1,954,420 shares
|
— | 02 Nov 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
35
Shares
24,778,477
Rows available
35
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
48
Q2 2022 holders
35
Holder diff
-13
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend